Risk factors for progression in patients with KDOQI stage 3 Chronic Kidney Disease (PROGRESER study) Alberto Martínez-Castelao; José Luis Górriz Teruel; Luis D¿Marco; Enrique Garrigós; Gema Fernández-Fresnedo; Eugenia Espinel Garuz; Secundino Cigarrán Guldris; Jesús Arteaga Coloma; Nicolas Roberto Robles Pérez-Monteoliva; José Rafael Esteban de la Rosa; Luis Javier Nieto Iglesias; Alberto Ortiz Arduán; Juan Francisco Navarro-González;

Unresolved aspects in the management of renal anemia, a Delphi consensus of the Anemia Group of the S.E.N José Portolés; Alejandro Martín-Malo; Leyre Martín-Rodríguez; Gema Fernández-Fresnedo; Patricia De Sequera; José Emilio Sánchez; Alberto Ortiz-Arduan; Aleix Cases;

Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression Luis Martín-Penagos; Gema Fernández-Fresnedo; Adalberto Benito-Hernández; Jaime Mazón; Marina de Cos; María Victoria Oviedo; David San Segundo; Marcos López-Hoyos; Javier Gómez-Román; Juan Carlos Ruiz; Emilio Rodrigo;